跳至主要内容
临床试验/NCT01122004
NCT01122004Unknown1 期

The Effect of Gabapentin (Neurentin) and Pregabalin (Lyrica) in Pain Reduction After Photorefractive Keratectomy

Shahid Beheshti University of Medical Sciences1 个研究点 分布在 1 个国家开始时间: 2010年5月12日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
试验地点
1
主要终点
pain degree based on visual analog scale(VAS)

研究概览

简要总结

The studied patients will be given randomly one of three following drugs1:Gabapentin2: Pregabalin or placebo for 3 days after Photorefractive keratectomy surgery. The pain will be measured based on visual analog scale(VAS) on the day of operation and on the 3 rd day (morning, evening) and then compared among three groups.

研究设计

研究类型
Interventional
主要目的
Treatment

入排标准

年龄范围
17 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients candidate for PRK, 17<age<70

排除标准

  • use of any systemic analgesic drugs, drug intolerance, need of systemic or topical administration of NSAIDs or eye drops for allergy and glaucoma, dry eyes, pregnancy, breast feeding

研究组 & 干预措施

Gabapentin

Active Comparator

干预措施: Pregabalin (Drug)

Pregabalin

Active Comparator

干预措施: Pregabalin (Drug)

结局指标

主要结局

pain degree based on visual analog scale(VAS)

次要结局

未报告次要终点

研究者

研究点 (1)

Loading locations...

相似试验